Evidence map›Paper›PMID 28521775›Full record

ArticleRespiratory research2017

Genome-wide association study of subclinical interstitial lung disease in MESA.

Ani Manichaikul, Xin-Qun Wang, Li Sun, Josée Dupuis, Alain C Borczuk, Jennifer N Nguyen, Ganesh Raghu, Eric A Hoffman, Suna Onengut-Gumuscu, Emily A Farber and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Respiratory research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Review
  6. Article
  7. [Research Progress of Anti-lung Cancer Drug-related Interstitial Lung Disease].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genetic Associations with Coronavirus Susceptibility and Disease Severity.Advances in experimental medicine and biology · 2023
    Review
  13. The human genetic epidemiology of COVID-19.Nature reviews. Genetics · 2022
    Review
  14. The genetic and evolutionary determinants of COVID-19 susceptibility.European journal of human genetics : EJHG · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

Ani ManichaikulCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA. amanicha@virginia.edu.
Xin-Qun WangDepartment of Public Health Sciences, Biostatistics Section, University of Virginia, Charlottesville, VA, USA.
Li SunDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Josée DupuisDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Alain C BorczukDepartment of Pathology, Weill Cornell Medicine, New York, NY, USA.
Jennifer N NguyenCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Ganesh RaghuUniversity of Washington Center for Interstitial Lung Diseases, Seattle, WA, USA.
Eric A HoffmanDepartment of Radiology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Suna Onengut-GumuscuCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Emily A FarberCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Joel D KaufmanDepartmenst of Environmental & Occupational Health Sciences, Medicine, and Epidemiology, University of Washington, Seattle, WA, USA.
Dan RabinowitzDepartment of Statistics, Columbia University, New York, NY, USA.
Karen D Hinckley StukovskyDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Steven M KawutDepartment of Medicine and Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gary M HunninghakeDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
George R WashkoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
George T O'ConnorThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
Stephen S RichCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
R Graham BarrDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
David J LedererDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
University of Virginia · USColumbia University · USUniversity of Washington · USBrigham and Women's Hospital · USCornell University · USFramingham Heart Study · USNational Heart Lung and Blood Institute · USUniversity of Iowa · USUniversity of Pennsylvania · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)R01HL093081 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2008 to 2026
$17.2M
UCLA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033176 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2011 to 2011
$15.5M
Multi-Ethnic Study of Atherosclerosis (MESA) StudyR01HL071205 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI ROTTER, JEROME I · 2003 to 2007
$10.4M
Subclinical Interstitial Lung Disease in MESA and FAR-ILDR01HL103676 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GARCIA, CHRISTINE KIM · 2011 to 2020
$6.4M
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4M
NCATS NIH HHS KL2 TR000081NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001079NCRR NIH HHS UL1 RR033176NHLBI NIH HHS HHSN268201500003CNHLBI NIH HHS K23 HL086714NHLBI NIH HHS K24 HL131937NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01 HC095160NHLBI NIH HHS N01 HC095161NHLBI NIH HHS N01 HC095162NHLBI NIH HHS N01 HC095163NHLBI NIH HHS N01 HC095164NHLBI NIH HHS N01 HC095165NHLBI NIH HHS N01 HC095166NHLBI NIH HHS N01 HC095167NHLBI NIH HHS N01 HC095168NHLBI NIH HHS N01 HC095169NHLBI NIH HHS N02 HL064278NHLBI NIH HHS R01 HL071051NHLBI NIH HHS R01 HL071205NHLBI NIH HHS R01 HL071250NHLBI NIH HHS R01 HL071251NHLBI NIH HHS R01 HL071258NHLBI NIH HHS R01 HL071259NHLBI NIH HHS R01 HL077612NHLBI NIH HHS R01 HL093081NHLBI NIH HHS R01 HL103676NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01 HL112986NHLBI NIH HHS R01 HL131565NHLBI NIH HHS RC1 HL100543NIDDK NIH HHS P30 DK054759NIDDK NIH HHS P30 DK063491NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

backgroundWe conducted a genome-wide association study (GWAS) of subclinical interstitial lung disease (ILD), defined as high attenuation areas (HAA) on CT, in the population-based Multi-Ethnic Study of Atherosclerosis Study.

methodsWe measured the percentage of high attenuation areas (HAA) in the lung fields on cardiac CT scan defined as voxels with CT attenuation values between -600 and -250 HU. Genetic analyses were performed in MESA combined across race/ethnic groups: non-Hispanic White (n = 2,434), African American (n = 2,470), Hispanic (n = 2,065) and Chinese (n = 702), as well as stratified by race/ethnicity.

resultsAmong 7,671 participants, regions at genome-wide significance were identified for basilar peel-core ratio of HAA in FLJ35282 downstream of ANRIL (rs7852363, P = 2.1x10

conclusionsOur results suggest novel roles for protein glycosylation and cell cycle disinhibition by long non-coding RNA in the pathogenesis of ILD.

Indexed as

AdultAgedAged, 80 and overAsian PeopleBlack or African AmericanFemaleGenome-Wide Association StudyHispanic or LatinoHumansLongitudinal StudiesLung Diseases, InterstitialMaleMiddle AgedPolymorphism, Single NucleotidePopulation SurveillanceWhite PeopleEpidemiologyGeneticsGenome-wide association studyInterstitial lung disease

Identifiers

PMID28521775
PMCPMC5437638
OpenAlexW2616499114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.